powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1033599162
Sheila Maier
D.O.
Endocrinology
Denver,
CO
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CCN 060014
Hospital
CCN 220012
Hospital
CCN 220135
Hospital
QUALITY · MIPS · 2024
Final MIPS score
76.2
Quality
56.8
Cost
72.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.05%
Group
PRESCRIBING · PART D · 2024
Total Rx claims
4,543
Beneficiaries
—
Total drug cost
$2.7M
Distinct drugs
45
Brand share
67.1%
Top prescribed drugs
Levothyroxine Sodium
481 claims
Metformin Hcl
348 claims
Semaglutide
334 claims
Dulaglutide
276 claims
Empagliflozin
271 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$955
Payment records
45
By payment type
Food and Beverage
$955
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,860
Unique beneficiaries
—
Total services
2,516
Distinct HCPCS
8
Medicare payment
$109K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 88 Endocrinology providers in CO — top quintile (cohort median 493).
